Financial statements Expresspharm

Balance sheet of Expresspharm

Company age:
Age:
9 y. 2 m. 21 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of EXPRESSPHARM

Year
2018
2019
2020
2021
2022
2023
Total assets 53 964,88 100 742,45 142 484,02 262 963,14 13 545,00 28 043,19
A. Fixed assets - 0,00 - - - -
B. Current assets 53 964,88 100 742,45 142 484,02 262 963,14 13 545,00 28 043,19
C. Share capital contributions (basic funds) - - - - - -
D. Own shares (stocks) - - - - - -
Total liabilities 5 396 488,00 100 742,45 142 484,02 262 963,14 13 545,00 28 043,19
A. Equity 42 074,53 80 177,22 121 539,57 220 217,90 -70 135,42 -64 030,86
B. Liabilities and provisions for liabilities 11 890,35 20 565,23 20 944,45 42 745,24 83 680,42 92 074,05
I. Long-term liabilities - - - - - -
II. Short-term liabilities - - - - - -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.